Supernus INDV
NASDAQ INDV
$36.25 +0.88 (+2.49%)
At close: Nov 2, 2026 · 4:00 PM EST

Supernus (INDV) Price to Earnings (2023 - 2026)

Updated

Indivior Pharmaceuticals' (INDV) Price to Earnings came in at 9.40 for Q3 2026, down 60.0% from 23.52 a year earlier and down 31.1% from the prior quarter.

Analysis

Supernus (INDV) Price to Earnings (2023 - 2026) Analysis & Trends

For FY2025, Indivior Pharmaceuticals' Price to Earnings stood at 21.37, down 90.3% from FY2024.

  • In prior years, Indivior Pharmaceuticals' Price to Earnings was 221.35 in FY2024 and 12.26 in FY2021.
  • According to Business Quant data, Price to Earnings for the three prior quarters was 13.64 (Q2 2026), 14.81 (Q1 2026) and 21.47 (Q4 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11.29
Jun 30, 2026 15.46
Mar 31, 2026 25.11
Dec 31, 2025 29.74
Sep 30, 2025 46.62
Jun 30, 2025 36.41
Dec 31, 2024 643.94
Sep 30, 2024 19.69
Jun 30, 2024 10.35
Mar 31, 2024 9.56
Dec 31, 2023 8.44
Sep 30, 2023 9.09
Jun 30, 2023 14.00
Mar 31, 2023 16.37
API Access

Supernus Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=INDV&period=max&api_key=YOUR_API_KEY